These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6401779)

  • 41. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
    Nathan CF; Murray HW; Wiebe ME; Rubin BY
    J Exp Med; 1983 Sep; 158(3):670-89. PubMed ID: 6411853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes.
    Welte K; Andreeff M; Platzer E; Holloway K; Rubin BY; Moore MA; Mertelsmann R
    J Exp Med; 1984 Nov; 160(5):1390-403. PubMed ID: 6092510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferons, a group of multiple lymphokines.
    Kirchner H
    Springer Semin Immunopathol; 1984; 7(4):347-74. PubMed ID: 6084313
    [No Abstract]   [Full Text] [Related]  

  • 44. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
    Carvalho EM; Badaró R; Reed SG; Jones TC; Johnson WD
    J Clin Invest; 1985 Dec; 76(6):2066-9. PubMed ID: 3935667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.
    Zoumbos NC; Gascon P; Djeu JY; Young NS
    Proc Natl Acad Sci U S A; 1985 Jan; 82(1):188-92. PubMed ID: 3918301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines.
    Sewell WA; de Moerloose PA; Hamilton JA; Schrader JW; Mackay IR; Vadas MA
    Immunology; 1987 Aug; 61(4):483-8. PubMed ID: 3127325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of 2',5'-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: dependence of biological effect on administration route.
    Rosenblum MG; Riso A; Gutterman JU
    Cancer Chemother Pharmacol; 1986; 16(3):273-6. PubMed ID: 3084109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome.
    Murray HW; Welte K; Jacobs JL; Rubin BY; Mertelsmann R; Roberts RB
    J Clin Invest; 1985 Nov; 76(5):1959-64. PubMed ID: 2997299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human T cell leukemia virus-I-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative disease.
    Levitt LJ; Reyes GR; Moonka DK; Bensch K; Miller RA; Engleman EG
    J Clin Invest; 1988 Feb; 81(2):538-48. PubMed ID: 2892860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages.
    Murray HW; Szuro-Sudol A; Wellner D; Oca MJ; Granger AM; Libby DM; Rothermel CD; Rubin BY
    Infect Immun; 1989 Mar; 57(3):845-9. PubMed ID: 2492973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma.
    Kwok AY; Zu X; Yang C; Alfa MJ; Jay FT
    Immunology; 1993 May; 79(1):131-7. PubMed ID: 7685313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
    Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
    Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon.
    Rubin BY; Bartal AH; Anderson SL; Millet SK; Hirshaut Y; Feit C
    J Immunol; 1983 Mar; 130(3):1019-20. PubMed ID: 6401779
    [No Abstract]   [Full Text] [Related]  

  • 54. Monoclonal antibodies neutralizing the antiviral and the antiproliferative activities of human interferon gamma.
    Kontsek P; Borecký L; Kontseková E; Sujanová Z; Novák M
    Acta Virol; 1988 Jul; 32(4):334-8. PubMed ID: 2903638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
    Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
    Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The enhancement of human tumor necrosis factor-alpha antiviral activity in vivo by monoclonal and specific polyclonal antibodies.
    Lidbury BA; Aston R; Ramshaw IA; Cowden WB; Rathjen DA
    Lymphokine Cytokine Res; 1993 Apr; 12(2):69-74. PubMed ID: 8324079
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.